PET for Dementia Trials

Additionally, in a National Coverage Determination for PET (FDG) for Dementia and Neurodegenerative Diseases (220.6.13) the Centers for Medicare & Medicaid Services (CMS) indicated that an FDG-PET scan is considered reasonable and necessary in patients with mild cognitive impairment or early dementia only in the context of an approved clinical trial that contains patient safeguards and protections to ensure proper administration, use and evaluation of the FDG-PET scan.

Facility Name	Provider Number	Date Approved	State
Facility Name Cedars-Sinai Medical Center	Provider Number 95 1644600	Date Approved 2009-10-09	State California
Facility Name Center for Alzheimer's Care, Imaging and Research (University of Utah)	Provider Number 460009	Date Approved 2009-02-17	State Utah
Facility Name Medical University of South Carolina	Provider Number 1073605879	Date Approved 2009-02-17	State South Carolina
Facility Name Santa Monica-UCLA Medical Center	Provider Number W11817A	Date Approved 2007-01-12	State California
Facility Name UCLA Medical Center	Provider Number HW13029	Date Approved 2006-06-07	State California
Facility Name University of Buffalo	Provider Number 14414A	Date Approved 2007-03-12	State New York